Company Overview and News
Honeywell International Inc. (HON - Free Report) recently announced the availability of Aspire 400, its newest satellite communications system. Apart from offering critical cockpit safety services to pilots, the system provides passengers and aircraft flight crews with an access to global voice and data connectivity. Also, it ensures safer and more efficient flights for business jets, commercial and military aircraft by offering a simultaneous connectivity to both the cockpit and the cabin.
Honeywell International Inc. (HON - Free Report) inked a fresh three-year contract with Asia Pacific’s biggest business aviation operator — Deer Jet — in a bid to extend the latter’s aircraft protection plan. Per the deal, Deer Jet will enroll nine aircrafts into Honeywell Mechanical Protection Plan (MPP) and additional 12 aircrafts in Honeywell Avionics Protection Plan (HAPP). Honeywell’s premium protection and maintenance service program, HAAP, offers cost effective and speedy avionics assistance to general, as well as business aviation operators.
SIOUX FALLS, S.D., April 16, 2018 (GLOBE NEWSWIRE) -- Raven Industries (NASDAQ:RAVN), a global leader in precision agriculture technologies, announced today its expansion into Brazil with the opening of a regional headquarters in Paulínia, São Paulo.
SIOUX FALLS, S.D., April 16, 2018 (GLOBE NEWSWIRE) -- A Raven Industries (NASDAQ:RAVN), líder global em tecnologias de agricultura de precisão, anunciou hoje sua expansão para o Brasil com a inauguração de uma sede regional em Paulínia, São Paulo.
SIOUX FALLS, S.D., April 16, 2018 (GLOBE NEWSWIRE) -- Raven Industries (NASDAQ:RAVN), líder mundial en tecnologías de agricultura de precisión, anunció hoy su expansión a Brasil con la apertura de una sede regional en Paulínia, São Paulo.
First-quarter 2018 earnings growth is expected to be in double-digits on a year-over-year basis for 11 of the 16 Zacks sectors. In all the sectors, the Conglomerates space is among the handful whose earnings are expected to contract year over year in the to-be-reported quarter.
General Electric Company’s (GE - Free Report) Renewable Energy segment recently signed a contract with Mass Energy Group Holding — a subsidiary of Mass Global — for the development of 100 MW Mass Wind project in Jordan.
Honeywell International Inc. (HON - Free Report) recently announced the availability of Aspire 40, its newest satellite communications system. Apart from offering critical cockpit safety services to pilots, the system provides passengers and aircraft flight crews with an access to global voice and data connectivity. Also, it ensures safer and more efficient flights for business jets, commercial and military aircraft by offering a simultaneous connectivity to both the cockpit and the cabin.
Shares of Leucadia National Corporation (LUK - Free Report) rose 11.6% on Apr 9, (its biggest jump since 2009) after the diversified conglomerate disclosed the divesture of its auto dealer group and a portion of its stake in its beef cattle business for roughly $1.33 billion. The company is reorganising operations to focus on investment banking and advisory services, as it plans to capitalize on the growth opportunities in the finance field.
General Electric Company’s (GE - Free Report) Energy Financial Services unit recently received $150 million project financing for refinancing and expansion of the Los Guindos open-cycle thermoelectric power plant, based in central Chile. Notably, GE Energy Financial Services holds a 75% stake in the power plant, with the remaining being owned by The Ingelec Group.
Document UNITED STATES
General Electric Company’s (GE - Free Report) Power segment recently entered into an agreement with Edison — the second largest integrated energy company in Italy — to improve performance at the latter’s Candela combined-cycle power station based in Puglia. Per the deal, General Electric will be assigned the task of installing its industry-leading Advanced Gas Path ("AGP") technology at the plant. This, in turn, might improve the company’s operational performance as well as flexibility with more output, efficiency and availability.
A month has gone by since the last earnings report for Raven Industries, Inc. (RAVN - Free Report) . Shares have added about 2.4% in that time frame.
Honeywell International Inc. (HON - Free Report) recently announced the expansion of its GoDirect connected services to the ground, which is one of the last unconnected aerospace frontiers. This latest move will take effect through a collaboration with the global telematics company, Pinnacle, and enable both the companies to connect an airport's ramp service to one single managed solution. Also, it will offer real-time insights into vehicle activity at the airport, resulting in greater fuel efficiency, better on-time performance and lower maintenance costs.
On Mar 28, we updated the research report on industrial goods manufacturer, Honeywell International Inc. (HON - Free Report) . With a flexible yet disciplined focus on cost and productivity, Honeywell aims at increasing its presence in high-growth regions. Population growth, urbanization and infrastructure development continue creating attractive opportunities across its entire portfolio. The company’s balanced mix of long- and short-cycle businesses along with a decent organic growth in new products and expansion in high-growth regions augur well on a long-term perspective.
2018-04-18 - Asif
History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...
2018-04-16 - Asif
Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...
2018-04-16 - Asif
Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...
2018-04-15 - Asif
Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...
2018-04-12 - Asif
Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...
as of ET